Viridian Therapeutics, Kissei Pharmaceutical Partner for Japanese Development of Thyroid Eye Disease Therapies, Securing $70M Upfront
Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best small cap stocks with biggest upside potential.
Viridian Therapeutics Inc. (VRDN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Soleus Capital Guy Levy | 0 | $0 | 0% | |
| 4. | Driehaus Capital Richard Driehaus | 0 | $0 | 0% | |
| 5. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.41 | 5,000 | $117,050.00 | 6,000 | 2024-09-27 | Filing | |
| $23.33 | 21,400 | $499,262.00 | 21,400 | 2024-09-27 | Filing | |
| $18.75 | 1,600,000 | $30,000,000.00 | 3,445,813 | 2024-09-13 | Filing | |
| $21.00 | 476,190 | $9,999,990.00 | 1,839,954 | 2024-01-22 | Filing | |
| $25.37 | 4,000 | $101,478.80 | 259,500 | 2023-04-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.35 | 27 | $765.45 | 29,971 | 2023-06-16 | Filing | |
| $28.02 | 2,269 | $63,577.38 | 29,971 | 2023-06-15 | Filing | |
| $25.02 | 5,126 | $128,252.52 | 29,971 | 2023-06-06 | Filing | |
| $25.03 | 499 | $12,489.97 | 29,971 | 2023-06-05 | Filing | |
| $24.21 | 1,875 | $45,393.75 | 29,971 | 2023-06-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
9 Best Small Cap Stocks with Biggest Upside Potential
On August 14, Jonathan Krinsky of BTIG, joined 'Closing Bell' on CNBC to discuss whether the recent rally in small cap stocks is sustainable.
Viridian Therapeutics' Veligrotug Shows Durable Proptosis Response in Phase 3 TED Trial
Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now.
13 Best Low Priced Pharma Stocks to Buy Now
On July 9, Afsaneh Beschloss, RockCreek Group founder & CEO, joined 'Closing Bell Overtime' on CNBC to talk about the latest round of tariff threats.
10 Best Small-Cap Stocks Ready To Explode
On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, discussed the outperformance of small-cap stocks.
8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2024 Earnings Call Transcript
Viridian Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.00079, expectations were $-1.07.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Viridian Therapeutics First Quarter 2023 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
